Universal Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 10 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
- Satisfied Charges ₹ 1.30 Cr
- Revenue Growth -55.77%
- Profit Growth 35.01%
- Ebitda 75.08%
- Net Worth -40.82%
- Total Assets -1.02%
About Universal Therapeutics
Universal Therapeutics Private Limited (UTPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 2014 and has a history of Ten years and eight months. Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹1.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Usha Puvvada and Ramakrishna Puvvada serve as directors at the Company.
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232AP2014PTC094531
- Company No.
094531
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Universal Therapeutics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Usha Puvvada  | Managing Director | 06-Jun-2014 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakrishna Puvvada | Director | 06-Jun-2014 | Current |
Financial Performance of Universal Therapeutics.
Universal Therapeutics Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 55.77% decrease. The company also saw a substantial improvement in profitability, with a 35.01% increase in profit. The company's net worth observed a substantial decline by a decrease of 40.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Universal Therapeutics?
In 2019, Universal Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Proteus Health Care Private LimitedUsha Puvvada and Ramakrishna Puvvada are mutual person
Best Imaging And Diagnostics Private LimitedUsha Puvvada and Ramakrishna Puvvada are mutual person
- Teja Hospitals Private Limited
Usha Puvvada is a mutual person
- Save Life Hospitals India Private Limited
Ramakrishna Puvvada is a mutual person
Charges (Loans)
₹15.00 M
₹13.00 M
Charges Breakdown by Lending Institutions
- Others : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2016 | Others | ₹1.50 Cr | Open |
| 22 Jan 2016 | Oriental Bank Of Commerce | ₹2.50 M | Satisfied |
| 20 Jun 2014 | Oriental Bank Of Commerce | ₹1.05 Cr | Satisfied |
How Many Employees Work at Universal Therapeutics?
Unlock and access historical data on people associated with Universal Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Universal Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
